FAS and non-small cell lung carcinoma: By studying 338 patients with early non-small cell lung cancer (NSCLC) who underwent surgical resection, Park et al. found that the FAS rs1800682 T/C polymorphism may affect the survival of early NSCLC, and that the survival rate of patients with the C/C genotypes was significantly lower than those with the T/T genotype [24].